8.56

3.38% 0.28

Treace Medical Concepts Inc (TMCI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$8.28

Aprire:

$8.36

Volume 24 ore:

261.27K

Relative Volume:

0.46

Capitalizzazione di mercato:

$527.03M

Reddito:

$198.53M

Utile/perdita netta:

$-63.68M

Rapporto P/E:

-11.73

EPS:

-0.73

Flusso di cassa netto:

$-41.50M

1 W Prestazione:

+7.27%

1M Prestazione:

+82.52%

6M Prestazione:

+65.89%

1 anno Prestazione:

-3.06%

Intervallo 1D:

$8.36

$8.60

Intervallo di 1 settimana:

$7.735

$8.75

Portata 52W:

$3.92

$15.98

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Nome

Treace Medical Concepts Inc

Settore

Healthcare (1200)

Industria

Medical Devices (153)

Telefono

(904) 373-5940

Indirizzo

100 PALMETTO PARK PLACE, PONTE VEDRA

Dipendente

227

Cinguettio

Prossima data di guadagno

2024-11-05

Ultimi documenti SEC

TMCI's Discussions on Twitter

Confronta TMCI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TMCI Treace Medical Concepts Inc	8.56	527.03M	198.53M	-63.68M	-41.50M	-0.73
ABT Abbott Laboratories	118.95	208.18B	41.22B	5.77B	6.49B	2.94
SYK Stryker Corp	388.14	148.70B	21.97B	3.59B	3.21B	6.74
BSX Boston Scientific Corp	90.75	133.32B	15.91B	1.79B	1.89B	0.82
MDT Medtronic Plc	86.27	111.27B	33.00B	4.29B	5.50B	2.71
EW Edwards Lifesciences Corp	72.07	42.66B	6.60B	4.16B	490.10M	2.34

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-05-16	Downgrade	UBS	Buy → Neutral
2024-05-08	Downgrade	BTIG Research	Buy → Neutral
2024-05-08	Downgrade	JP Morgan	Overweight → Neutral
2024-05-08	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-05-08	Downgrade	Stifel	Buy → Hold
2024-05-08	Downgrade	Truist	Buy → Hold
2023-09-29	Iniziato	UBS	Buy
2023-05-01	Iniziato	Truist	Buy
2023-04-11	Iniziato	Stephens	Equal-Weight
2022-05-12	Iniziato	BTIG Research	Buy
2022-01-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-05-18	Iniziato	JP Morgan	Overweight
2021-05-18	Iniziato	Morgan Stanley	Equal-Weight
2021-05-18	Iniziato	SVB Leerink	Outperform
2021-05-18	Iniziato	Stifel	Buy

Mostra tutto

Treace Medical Concepts Inc Borsa (TMCI) Ultime notizie

Nov 27, 2024

Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $7.40 - Defense World

Nov 27, 2024

Nov 26, 2024

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - GuruFocus.com

Nov 26, 2024

Nov 24, 2024

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Nov 24, 2024

Nov 18, 2024

Treace Announces Participation at Stifel 2024 Healthcare Conference - The Manila Times

Nov 18, 2024

Treace Medical CEO to Present at Stifel 2024 Healthcare Conference | TMCI Stock News - StockTitan

Nov 18, 2024

Nov 15, 2024

Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 15, 2024

Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires Significant Stake in Treace Medi - GuruFocus.com

Nov 14, 2024

Nov 09, 2024

Treace Medical Concepts Reports Strong Q3 2024 Growth - TipRanks

Nov 09, 2024

Morgan Stanley's Strategic Reduction in Treace Medical Concepts Inc. - GuruFocus.com

Nov 09, 2024

Nov 07, 2024

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024

Nov 06, 2024

Earnings call: Treace Medical Concepts reported an 11% increase in third-quarter revenue - Investing.com India

Nov 06, 2024

U.S. Stock market: SONN(+86.46%), DataChat(+50.28%), Cytek Biosciences(+30.51%) among the top gainers during early trading - Business Upturn

Nov 06, 2024

Treace Medical (TMCI) Experiences Stock Boost After Reporting Strong Results - Stocks Telegraph

Nov 06, 2024